(0.62%) 5 113.75 points
(0.09%) 38 321 points
(0.85%) 17 717 points
(0.12%) $83.67
(-3.36%) $1.583
(0.90%) $2 363.60
(1.25%) $27.70
(0.47%) $924.80
(-0.01%) $0.932
(0.26%) $10.98
(-0.02%) $0.799
(-0.12%) $92.06
Live Chart Being Loaded With Signals
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD)...
Stats | |
---|---|
Today's Volume | 1.79M |
Average Volume | 1.22M |
Market Cap | 9.56B |
EPS | $-0.860 ( 2023-08-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -56.47 |
ATR14 | $2.40 (1.20%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-16 | Hendrix Martin | Sell | 2 071 | Common Stock |
2023-06-16 | Hendrix Martin | Sell | 40 000 | Stock Option (right to buy) |
2023-06-16 | Hendrix Martin | Sell | 20 500 | Stock Option (right to buy) |
2023-06-16 | Laur James | Sell | 2 071 | Common Stock |
2023-06-16 | Laur James | Sell | 40 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
-86.76 |
Last 100 transactions |
Buy: 394 552 | Sell: 5 154 734 |
Volume Correlation
Prometheus Biosciences, Correlation
10 Most Positive Correlations | |
---|---|
AVEO | 0.965 |
ITMR | 0.949 |
HZNP | 0.941 |
DVCR | 0.939 |
MLCO | 0.932 |
OPNT | 0.932 |
AVAC | 0.929 |
LUNA | 0.925 |
EWEB | 0.923 |
ALXN | 0.914 |
10 Most Negative Correlations | |
---|---|
HLXA | -0.95 |
THTX | -0.933 |
ENPH | -0.932 |
XFOR | -0.931 |
AVO | -0.93 |
GRIN | -0.924 |
GOSS | -0.917 |
ATAI | -0.912 |
ZSAN | -0.907 |
CFBK | -0.906 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Prometheus Biosciences, Correlation - Currency/Commodity
Prometheus Biosciences, Financials
Annual | 2023 |
Revenue: | $6.81M |
Gross Profit: | $6.81M (100.00 %) |
EPS: | $-3.49 |
FY | 2023 |
Revenue: | $6.81M |
Gross Profit: | $6.81M (100.00 %) |
EPS: | $-3.49 |
FY | 2022 |
Revenue: | $3.13M |
Gross Profit: | $3.13M (100.00 %) |
EPS: | $-2.87 |
FY | 2020 |
Revenue: | $1.23M |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.376 |
Financial Reports:
No articles found.
Prometheus Biosciences,
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated interstitial lung disease. The company also develops PR600, an anti-tumor necrosis factor mAb for IBD; PR300, a G-protein coupled receptor modulator small molecule for IBD; PR1100, an anti-cytokine receptor mAb for IBD and other immune-mediated diseases; PR1800, an anti-chemokine mAb for IBD; and PR2100, an anti-inflammatory cytokine mAb for IBD. It has a diagnostics development and collaboration agreement with Takeda Pharmaceutical Company Limited; co-development and manufacturing agreement with Dr. Falk Pharma GmbH; license agreement with Cedars-Sinai Medical Center; and strategic collaboration with Millennium Pharmaceuticals, Inc. The company was formerly known as Precision IBD, Inc. and changed its name to Prometheus Biosciences, Inc. in October 2019. Prometheus Biosciences, Inc. was incorporated in 2016 and is headquartered in San Diego, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators